Peter DeMuth - 16 Dec 2024 Form 4 Insider Report for Elicio Therapeutics, Inc. (ELTX)

Role: Chief Scientific Officer
Signature: /s/ Peter DeMuth
Issuer symbol: ELTX
Transactions as of: 16 Dec 2024
Net transactions value: +$1,680
Form type: 4
Filing time: 18 Dec 2024, 16:51:33 UTC
Previous filing: 02 Oct 2024
Next filing: 04 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELTX	Common Stock	Options Exercise	$1,680	+381		$4.41	381	16 Dec 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELTX	Stock Option (Right to Buy)	Options Exercise	$0	-381	-100%	$0.000000	0	16 Dec 2024	Common Stock	381	$4.41	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock option vested and became exercisable as to (i) 25% of the options on the first anniversary of the grant date or December 18, 2015, and (ii) with the remaining shares vesting at a rate of 2.0833% at the end of each month thereafter.